Equities

Monogram Technologies Inc

Monogram Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.15
  • Today's Change-0.07 / -3.15%
  • Shares traded48.47k
  • 1 Year change-12.96%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 18:02 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.

  • Revenue in USD (TTM)365.00k
  • Net income in USD-11.69m
  • Incorporated2016
  • Employees28.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medinotec Inc8.38m-21.86k58.67m35.00----755.657.00-0.0019-0.00190.71460.21561.645.0217.62239,561.70-0.4275---0.5122--42.89---0.2607--2.326.610.3165--402.25---14.73------
InspireMD Inc6.57m-25.52m61.31m65.00--1.29--9.34-0.7389-0.73890.19071.860.12022.574.73101,030.80-46.71-60.59-52.36-72.9723.8520.46-388.67-334.787.13--0.00--20.0011.50-7.71--41.57--
Pheton Holdings Ltd628.59k-241.22k61.99m11.00--170.44--98.61-0.0201-0.02010.05240.0255------57,144.55--------74.90---38.37--0.3984--0.00---7.53---387.24------
Heartbeam Inc0.00-16.91m62.93m15.00--7.20-----0.6375-0.63750.000.32780.00----0.00-106.50---113.62--------------0.00-------12.94------
iCAD Inc18.80m-4.54m63.70m67.00--2.04--3.39-0.1735-0.0880.71851.170.44881.063.14280,537.30-10.84-23.94-13.90-34.1486.0476.96-24.16-45.024.13--0.00---12.54-7.5329.32--23.88--
Vicarious Surgical Inc0.00-61.02m65.70m131.00--0.9116-----10.77-10.770.0012.220.00----0.00-61.68---66.62--------------0.00-------1,478.15------
Hyperfine Inc11.94m-41.45m67.61m131.00--1.01--5.66-0.5773-0.57730.16630.92480.12620.98562.5691,160.30-43.81---48.08--44.51---347.05--7.24--0.00--61.90--39.54------
Vivani Medical Inc0.00-24.20m69.07m44.00--2.90-----0.4643-0.46430.000.43160.00----0.00-44.89-56.58-50.97-67.66-------2,868.72----0.00-------84.69--40.33--
Modular Medical Inc0.00-17.87m73.91m39.00--9.22-----0.6986-0.69860.000.24620.00----0.00-150.56-187.51-167.12-234.72------------0.00-------25.87--85.63--
Xtant Medical Holdings Inc110.94m-3.33m74.90m207.00--1.56130.950.6752-0.0284-0.02840.84310.34541.381.406.35535,956.50-4.15-10.38-5.77-14.6861.6161.08-3.00-8.661.01-4.540.429--57.504.81107.78--18.47--
Baird Medical Investment Holdings Ltd0.00-4.88m76.81m----8.62-----0.7412-0.74120.000.34340.00-------14.19---20.29--------------0.3413-------627.59------
Monogram Technologies Inc365.00k-11.69m77.01m28.00--9.98--211.00-0.3745-0.37450.01180.22240.0239----13,035.71-76.61-119.26-117.14-257.400.00---3,203.87-5,045.60----0.00-------0.3964---15.97--
Work Medical Technology Group Ltd13.57m112.03k77.19m216.00685.237.7747.525.690.00770.00770.93560.68110.48892.104.1062,805.320.2284--0.6332--30.54--0.4673--0.92651.120.4459---31.18---87.05------
electroCore, Inc.21.28m-14.23m80.13m68.00--6.99--3.77-2.19-2.193.251.781.161.4154.85312,955.90-77.78-70.73-125.05-88.9683.6175.81-66.84-352.822.12--0.00--86.5774.4215.02---5.88--
LENSAR Inc45.12m-12.56m81.77m130.00--3.44--1.81-1.11-1.113.923.240.68061.259.08347,107.70-18.94-30.97-22.49-36.9449.8751.04-27.83-52.302.15--0.00--19.2511.5727.77---42.91--
Owlet Inc65.64m-15.92m82.65m76.00------1.26-1.89-1.897.61-2.291.273.484.39863,618.40-20.24---165.32--45.71---15.91--0.8168-40.50-----21.95--52.74------
Data as of Nov 13 2024. Currency figures normalised to Monogram Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

1.64%Per cent of shares held by top holders
HolderShares% Held
Buckingham Strategic Partners LLCas of 30 Jun 2024201.35k0.64%
The Vanguard Group, Inc.as of 30 Jun 2024158.83k0.50%
Commonwealth Equity Services LLCas of 30 Sep 202434.26k0.11%
New Harbor Financial Group LLCas of 30 Sep 202429.35k0.09%
BlackRock Fund Advisorsas of 30 Jun 202422.52k0.07%
UBS Securities LLCas of 30 Jun 202420.19k0.06%
HRT Financial LP (US)as of 30 Jun 202417.28k0.05%
Geode Capital Management LLCas of 30 Jun 202415.37k0.05%
OneDigital Investment Advisors LLCas of 30 Sep 202411.67k0.04%
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 20248.40k0.03%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.